Tabla de Contenidos: “…XX hasta el Código de NurembergLos experimentos militares sobre la fiebre amarilla; La investigación biomédica actual con seres humanos y la Declaración de Helsinki: insuficiencias del consentimiento informado y creación de otras medidas de protección; El estudio de Willowbrook sobre la hepatitis; El estudio Tuskegee sobre la sífilis; La Declaración de Helsinki…”

Tabla de Contenidos: “…Part 1: Cardiovascular Disorders -- Chapter 1: Chronic Heart Failure -- Chapter 2: Acute Decompensated Heart Failure -- Chapter 3: Hypertension -- Chapter 4: Acute Coronary Syndromes -- Chapter 5: Dyslipidemia -- Chapter 6: Stroke -- Chapter 7: Anticoagulation/Venous Thromboembolism -- Chapter 8: Peripheral Arterial Disease -- Chapter 9: Arrhythmia -- Part 2: Immunologic, Hematologic, and Oncologic Disorders -- Chapter 10: Oncology Overview and Supportive Care -- Chapter 11: Immune System -- Chapter 12: Anemia -- Chapter 13: Lung Cancer -- Chapter 14: Prostate Cancer -- Chapter 15: Leukemias -- Chapter 16: Breast Cancer -- Chapter 17: Solid Organ Transplantation -- Chapter 18: Cutaneous Melanoma -- Chapter 19: Colorectal Cancer -- Part 3: Infectious Diseases -- Chapter 20: Antimicrobial Regimen Selection -- Chapter 21: Lower Respiratory Tract Infections -- Chapter 22: Upper Respiratory Tract Infections -- Chapter 23: Urinary Tract Infections -- Chapter 24: Skin and Soft Tissue Infections -- Chapter 25: Central Nervous System Infections -- Chapter 26: Sepsis Syndromes -- Chapter 27: Human Immunodeficiency Virus -- Chapter 28: Opportunistic Infections -- Chapter 29: Invasive Fungal Infections -- Chapter 30: Tuberculosis -- Chapter 31: Sexually Transmitted Diseases -- Chapter 32: Influenza -- Part 4: Renal and Nutritional Disorders -- Chapter 33: Estimating Renal Function -- Chapter 34: Acute Kidney Injury -- Chapter 35: Chronic Kidney Disease/End Stage Renal Disease -- Chapter 36: Acid-Base Disorders -- Chapter 37: Enteral Nutrition -- Chapter 38: Parenteral Nutrition -- Chapter 39: Electrolyte Disorders -- Part 5: Gastrointestinal Disorders -- Chapter 40: Liver Cirrhosis and Complications -- Chapter 41: Inflammatory Bowel Disease -- Chapter 42: Nausea and Vomiting -- Chapter 43: Upper Gastrointestinal Disorders -- Chapter 44: Hepatitis -- Part 6: Respiratory Disorders -- Chapter 45: Chronic Obstructive Pulmonary Disease -- Chapter 46: Asthma -- Chapter 47: Cystic Fibrosis -- Part 7: Bone and Joint Disorders -- Chapter 48: Gout -- Chapter 49: Osteoporosis -- Chapter 50: Rheumatoid Arthritis -- Chapter 51: Osteoarthritis -- Part 8: Neurologic Disorders -- Chapter 52: Parkinson Disease -- Chapter 53: Epilepsy -- Chapter 54: Headache -- Chapter 55: Pain Management -- Part 9: Psychiatric Disorders -- Chapter 56: Schizophrenia -- Chapter 57: Anxiety Disorders -- Chapter 58: Bipolar Disorders -- Chapter 59: Post-Traumatic Stress Disorder -- Chapter 60: Depression -- Part 10: Endocrinologic Disorders -- Chapter 61: Diabetes Mellitus -- Chapter 62: Thyroid Disorders -- Part 11: Health and Wellness and Other Topics -- Chapter 63: Contraception -- Chapter 64: Allergic Rhinitis -- Chapter 65: Urology -- Chapter 66: Vaccines and Immunizations -- Chapter 67: Smoking Cessation -- Chapter 68: Ocular Pharmacology -- Chapter 69: Pregnancy and Lactation -- Chapter 70: Pharmacoeconomics -- Chapter 71: Statistics -- Chapter 72: Pharmacy Calculations -- Chapter 73: Clinical Toxicology -- Chapter 74: Herbal and Nonherbal Dietary Supplements -- Chapter 75: Sterile Compounding Regulations and Best Practices for Sterile Compounding per USP 797 According to the Official USP Chapter 797 -- Chapter 76: Compounding USP Chapter 800-Hazardous Drug Handling in Health Care Settings -- Appendix A: The Top 310 Medications -- Appendix B: Common Injectable Medications…”

Tabla de Contenidos: “…6.4 Tuberculosis -- 6.5 Hepatitis B and C -- 6.6 Malaria -- 6.7 Buruli ulcer -- 6.8 Leishmaniasis -- 6.9 Cervical cancer -- 6.10 Noncommunicable diseases -- 6.11 Mental health among people living with HIV -- 6.12 Drug use -- 6.13 Sexually transmitted infections -- 6.14 Vaccines for people living with HIV -- 6.15 HIV-related skin and oral conditions -- 6.16 Nutritional care and support -- 6.17 Palliative care -- 6.18 Noncommunicable diseases among children and adolescents -- SERVICE DELIVERY -- 7.1 Introduction -- 7.2 Linkage from HIV testing to enrolment in care -- 7.3 Differentiated service delivery for HIV treatment -- 7.4 People-centred care -- 7.5 Initiating and maintaining treatment -- 7.6 Continuity of care -- 7.7 Task sharing -- 7.8 Decentralization -- 7.9 Integrating services -- 7.10 Delivering HIV services to children -- 7.11 Service delivery for adolescents -- 7.12 Improving the quality of HIV care services -- 7.13 Procurement and supply management systems for HIV health products -- 7.14 Laboratory and diagnostic services -- 7.15 Laboratory connectivity -- MONITORING ART PROGRAMME FUNCTIONING -- 8.1 Introduction -- 8.2 Selection of key indicators to improve service delivery and assess impact -- 8.3 Data collection and disaggregation -- 8.4 Strengthening data systems -- 8.5 Evaluation, including impact and programme performance -- 8.6 Monitoring ARV drug toxicity -- 8.7 HIV drug resistance -- Publication, dissemination and evaluation -- 9.1 Publication -- 9.2 Dissemination and implementation -- 9.3 Useful analytical tools for planning -- 9.4 Evaluation -- Glossary -- ANNEX 1: DOSAGES FOR ARV DRUGS -- Annex 2: key drug interactions -- for aRVs -- 1.1 Background and rationale -- 1.2 Objectives -- 1.3 Target audience -- 1.4 Guiding principles -- 1.5 Methods for developing the guidelines -- 1.6 Organization of the guidelines…”

Tabla de Contenidos: “…Multiply resistant bacteria – reducing the spread. C-Diff. Hepatitis. Emerging infections (HepE). Paediatric considerations -- Chapter 8. …”

Tabla de Contenidos: “…. -- FIGURA 5.1. CAUSAS DE HEPATITIS -- FIGURA 5.2. REPRESENTACIÓN ESQUEMÁTICA DE LA REPERCUSIÓN METABÓLICA DEL (...) -- FIGURA 5.3. …”

Tabla de Contenidos: “…Level I oChapter 40: Nausea and Vomiting: In for a Tune-Up Level II oChapter 41: Diarrhea: Diner's Diarrhea Level I oChapter 42: Irritable Bowel Syndrome: Life in the Slow Lane Level II oChapter 43: Pediatric Gastroenteritis: One Thing You Should Try at Home Level II oChapter 44: Constipation: All Bound Up Level II oChapter 45: Ascites Management in Portal Hypertension and Cirrhosis: Back to Drinking Level II oChapter 46: Esophageal Varices: Banding the Bleeding Level I oChapter 47: Hepatic Encephalopathy: State of Confusion Level I oChapter 48: Acute Pancreatitis: A Sod Story Level II oChapter 49: Chronic Pancreatitis: Like a Shot to the Gut Level II oChapter 50: Viral Hepatitis A: Forbid Dual Infections Level II oChapter 51: Viral Hepatitis B: A Persistent Infection Level III oChapter 52: Viral Hepatitis C: Guidelines for Optimal Care De-LIVER-y Level II *Section 5: Renal Disorders Section Editor: Jill S. …”

Tabla de Contenidos: “…Dinneen, Molly Byrne -- The systematic approach to improving care for Frail Older Patients (SAFE) study: A protocol for co-designing a frail older person's pathway -- Éidín Ní Shé, Mary McCarthy, Deirdre O'Donnell, Orla Collins, Graham Hughes, Nigel Salter, Lisa Cogan, Coailfhionn O'Donoghue, Emmet McGrath, John O'Donovan, Andrew Patton, Eilish McAuliffe, Diarmuid O'Shea, Marie Therese Cooney -- Sexual transmission of Hepatitis C Virus infection in a heterosexual population: A systematic review -- Francesca Wuytack, Vittoria Lutje, Janus Christian Jakobsen, Karl Heinz Weiss, Paula Flanagan, Georgina Gethin, Louise Murphy, Siobhan Smyth, Declan Devane, Valerie Smith -- Assessment of the understanding of informed consent including participants' experiences, and generation of a supplemental consent decision aid for Gestational Diabetes Mellitus (GDM) research -- Shubham Atal, Fidelma Dunne -- A community-based parent-support programme to prevent child maltreatment: Protocol for a randomised controlled trial -- Mairead Furlong, Ann Stokes, Sinead McGilloway, Grainne Hickey, Yvonne Leckey, Tracey Bywater, Ciaran O'Neill, Chris Cardwell, Brian Taylor, Michael Donnelly, ENRICH Research Team -- Participants' perspectives and preferences on clinical trial result dissemination: The TRUST Thyroid Trial experience -- Emmy Racine, Caroline Hurley, Aoife Cheung, Carol Sinnott, Karen Matvienko-Sikar, Christine Baumgartner, Nicolas Rodondi, William H. …”

Tabla de Contenidos: “…Ocular and oral complications -- 49. Hepatic complications -- 50. Gastrointestinal complications -- 51. …”

Tabla de Contenidos: “…Ayudas sociales para afectados de determinadas enfermedades (VIH y hepatitis C)2.3. Ámbito II. Protección de la familia; 2.3.1. …”

Tabla de Contenidos: “…Biochemical and Biophysical Characterisation of the Hepatitis E Virus Guanine-7-Methyltransferase -- TanveerA.Wani,MohammedM.Alanazi,NawafA.Alsaif,AhmedH.Bakheit,SeemaZargar and Ommalhasan Mohammed Alsalami et al. …”

Tabla de Contenidos: “….-30 Basic Principles and Advanced VATS procedures -- Part 8 Upper Gastrointestinal Surgery - Esophageal Surgery -- 31 Achalasia -- 32 Resection of Gastroesophageal Junction Submucosal Tumours (SMTs) -- 33 Transoral Endoscopic Zenker Diverticulotomy -- 34 Gastroesophageal Reflux Disease -- 35 Hiatal Hernia -- 36 Esophageal Cysts -- 37 McKeown Esophagectomy -- Part 9 Upper Gastrointestinal Surgery - Gastric Surgery -- 38 Gastric Gastrointestinal Stromal Tumours -- 39 Gastric Carcinoma : Subtotal and Total Gastrectomy -- Part 10 Bariatric Procedures -- 40 Laparoscopic Gastric Banding for Morbid Obesity -- 41 Laparoscopic Sleeve Gastrectomy -- 42 Laparoscopic Roux En Y Gastric Bypass (LRYGB) -- 43 One Anastomosis Gastric Bypass (OAGB) -- Part 11 Hepatobiliary Surgery – Gallbladder -- 44 Elective Cholecystectomy -- Part 12 Hepatobiliary Surgery - Common Bile Duct Stones -- 45 Laparoscopic Choledochotomy for Bile Duct Stones -- Part 13 Hepatobiliary Surgery – Liver -- 46 Hepatic cyst/ abscess -- 47 Laparoscopic Wedge Liver Resection -- 48 Laparoscopic Left Liver Resection -- 49 Laparoscopic Right Hepatectomy -- Part 14 Pancreas -- 50 Laparoscopic internal drainage of pancreatic pseudocysts -- 51 Laparoscopic Distal Pancreatectomy -- 52 Laparoscopic Pancreaticoduodenectomy -- Part 15 Spleen -- 53 Laparoscopic Splenectomy -- 54 Intraoperative Splenic Injuries -- Part 16 Inguinal Hernia -- 55 Transabdominal Pre-peritoneal approach (TAPP) -- 56 Totally Extra-peritoneal approach in Inguinal Hernia Repair -- 57 Laparoscopic Management of Recurrent and Re-Recurrent hernia -- 58 Laparo-endoscopic approach to Complex Inguinal Hernia -- Part 17 Incisional/ Ventral Hernia Repair -- 59 Laparoscopic Intraperitoneal Onlay Mesh (IPOM) and IPOM plus -- 60 Extraperitoneal Ventral Hernia Repair -- 61 Endoscopic anterior component separation technique (eACS) -- 62 Role of Botulinum Toxin-A in Chemical Component Separation Technique.-63 Endo-Laparoscopic Repair of Lateral Ventral Hernia -- Part 18 Diastasis Recti -- 64 Posterior Plication or Combined Plication of the Recti Diastasis -- 65 Endo-laparoscopic retromuscular repair -- 66 Endoscopic Subcutaneous Onlay Laparoscopic Approach -- Part 19 Other Hernias -- 67 Minimally Invasive Surgery for Diaphragmatic Hernia -- 68 Laparoscopic Parastomal Hernia Repair -- Part 20 Colorectal Surgery -- 69 Laparoscopic Right Hemicolectomy with Complete Mesocolic Excision and Central Vascular Ligation (CME/CVL) for Right sided Colon Cancer -- 70 Laparoscopic left hemicolectomy -- 71 Anterior Resection -- 72 Laparoscopic Abdominoperineal Resection -- 73 Laparoscopic Total Colectomy -- 74 Laparoscopic Ventral Mesh Rectopexy -- Part 21 Robotic Surgery -- 75 Robotic Surgery - Operating Room Set Up and Docking -- Part 22 Other Laparoscopic Procedures -- 76 Laparoscopic Varicocoelectomy -- 77 Laparoscopic Paediatric Inguinal Hernia Repair…”

Tabla de Contenidos: “…Diagnóstico de enfermedades según la forma de las uñas de los dedos del pie -- Diagnóstico de enfermedades según el dolor en el pie -- Diagnóstico de enfermedades según la postura de los pies -- Diagnóstico de enfermedades según la piel del pie -- Diagnóstico de enfermedades según el arco del pie -- Diagnóstico de enfermedades según el aspecto general del pie -- Capítulo 5 -- Masaje de manos y pies para tratar varias enfermedades -- Resfriado -- Diarrea -- Estreñimiento -- Migraña -- Insomnio -- Obesidad -- Diabetes -- Hipertensión -- Hiperlipidemia -- Hígado graso -- Asma -- Enfermedad coronaria -- Gastritis crónica -- Úlcera gastroduodenal -- Hepatitis crónica -- Periartritis del hombro -- Rinitis crónica -- Gota -- Osteoporosis -- Artritis reumatoide -- Menstruación irregular -- Dismenorrea -- Amenorrea -- Mastitis -- Prolapso del útero -- Enfermedades de la leucorrea -- Inflamación pélvica -- Infertilidad -- Síndrome menopáusico -- Hipogalactia postparto -- Impotencia -- Eyaculación precoz -- Prostatitis crónica -- Hiperplasia prostática -- Espermatorrea -- Contracubierta…”

Tabla de Contenidos: “…Helminthic Agents Present in Seafood -- Trematodes -- Cestodes -- Nematodes -- Other Nematodes -- PATHOGENS ASSOCIATED WITH FECAL POLLUTION OF THE MARINE OR FRESHWATER ENVIRONMENT -- Viral Human Enteric Pathogens -- Hepatitis Type A (Enterovirus Type 72) -- Caliciviruses and Astroviruses -- Unclassified Viruses -- Disease Control for Human Enteric Viruses -- PROCESSING, DISTRIBUTION, AND PREPARATION-RELATED PUBLIC HEALTH HAZARDS -- Bacterial Pathogens -- Salmonella -- Epidemiology and risk assessment -- Disease control -- Campylobacter jejuni -- Escherichia coli -- Yersinia enterocolitica -- Listeria -- Epidemiology and risk assessment -- Disease control -- Clostridium botulinum -- Epidemiology and risk assessment -- Disease control -- Shigella -- Staphylococcus aureus -- Viral Pathogens -- Impact of Processing Technology -- Heat Treatment -- Modified Atmospheres and Vacuum Packaging -- PUBLIC HEALTH RISK ASSESSMENT -- Risk Assessment -- Hazard Identification -- Dose-Response Assessment -- Exposure Assessment -- Risk Characterization -- Risk Management -- Pathogens in Marine or Freshwater Environments -- Pathogens Associated with Pollution -- Pathogens Associated with Processing and Distribution -- Imports -- Future Risk -- Ethnic foods and regional considerations -- Aquaculture -- CONCLUSIONS AND RECOMMENDATIONS -- Conclusions -- Raw Molluscan Shellfish -- Other Seafoods -- Recommendations -- Specific Recommendations for Raw Molluscan Shellfish -- General Recommendations for All Seafoods -- NOTES -- REFERENCES -- 4 Naturally Occurring Fish and Shellfish Poisons -- ABSTRACT -- INTRODUCTION -- SPECIFIC INTOXICATIONS -- Ciguatera -- Scombroid (Histamine) Fish Poisoning -- Paralytic Shellfish Poisoning (PSP) -- Neurotoxic Shellfish Poisoning (NSP) -- Diarrhetic Shellfish Poisoning (DSP) -- Puffer Fish Poisoning (PFP) -- Amnesic Shellfish Poisoning (ASP)…”

Tabla de Contenidos: “…Schwinghammer -- Chapter 21: Cirrhosis and Portal Hypertension -- Chapter 22: Constipation -- Chapter 23: Diarrhea -- Chapter 24: Gastroesophageal Reflux Disease -- Chapter 25: Hepatitis, Viral -- Chapter 26: Inflammatory Bowel Disease -- Chapter 27: Nausea and Vomiting -- Chapter 28: Pancreatitis -- Chapter 29: Peptic Ulcer Disease -- SECTION 6: GYNECOLOGIC AND OBSTETRIC DISORDERS Edited by Vicki L. …”

Tabla de Contenidos: “…9.3 Estreñimiento -- 9.4 Diarrea -- 9.5 Disfagia -- 9.6 Dolor epigástrico -- 9.7 Hemorragia digestiva alta -- 9.8 Hepatitis -- 9.9 Hepatomegalia -- 9.10 Ictericia -- 9.11 Rectorragiaorrea -- 9.12 Esteatorrea -- 10 Problemas renales y urológicos -- 10.1 Disuria -- 10.2 Hematuria -- 10.3 Disfunción eréctil -- 10.4 Incontinencia urinaria -- 10.5 Nicturia -- 10.6 Oliguria y anuria -- 10.7 Priapismo -- 10.8 Masa escrotal -- 10.9 Dolor escrotal -- 10.10 Secreción uretral -- 11 Problemas relacionados con el aparato reproductor femenino -- 11.1 Amenorrea -- 11.2 Masa mamaria -- 11.3 Dolor pélvico crónico -- 11.4 Dismenorrea -- 11.5 Dispareunia -- 11.6 Menorragia -- 11.7 Secreción por el pezón en mujeres no gestantes -- 11.8 Prueba de Papanicoláu anómala -- 11.9 Sangrado posmenopáusico -- 11.10 Secreción vaginal -- 12 Problemas musculoesqueléticos -- 12.1 Artralgia -- 12.2 Dolor de pantorrilla -- 12.3 Dolor de cadera -- 12.4 Dolor de rodilla -- 12.5 Lumbalgia -- 12.6 Monoartralgia -- 12.7 Dolor cervical -- 12.8 Polimialgia -- 12.9 Dolor de hombro -- 13 Afecciones cutáneas -- 13.1 Alopecia -- 13.2 Eritema multiforme -- 13.3 Exantema maculopapular -- 13.4 Trastornos de la pigmentación -- 13.5 Prurito -- 13.6 Exantema acompañado de fiebre -- 13.7 Urticaria -- 13.8 Erupciones vesiculares y ampollosas -- 14 Endocrinopatías y metabolopatías -- 14.1 Diabetes mellitus -- 14.2 Ginecomastia -- 14.3 Hirsutismo -- 14.4 Hipotiroidismo -- 14.5 Polidipsia -- 14.6 Bocio -- 14.7 Nódulo tiroideo -- 14.8 Hipertiroidismo -- 14.9 Deficiencia de vitamina D -- 15 Alteraciones sistémicas vasculares y linfáticas -- 15.1 Linfadenopatía generalizada -- 15.2 Linfadenopatía localizada -- 15.3 Petequias y púrpura -- 15.4 Esplenomegalia -- 16 Anomalías en los análisis clínicos: determinaciones hematológicas y urinarias -- 16.1 Anemia -- 16.2 Eosinofilia…”

Tabla de Contenidos: “…COST INCURRED BY DISEASE -- VACCINE DEVELOPMENT -- VACCINE PROGRAM CONSIDERATIONS -- Target Population -- Vaccine Schedule, Efficacy, and Costs -- RESULTS -- READING LIST -- APPENDIX 6 Epstein-Barr Virus -- DISEASE BURDEN -- Epidemiology -- Disease Scenarios -- COST INCURRED BY DISEASE -- VACCINE DEVELOPMENT -- VACCINE PROGRAM CONSIDERATIONS -- Target Population -- Vaccine Schedule, Efficacy, and Costs -- RESULTS -- READING LIST -- APPENDIX 7 Helicobacter pylori -- DISEASE BURDEN -- Epidemiology -- Disease Scenarios -- COST INCURRED BY DISEASE -- VACCINE DEVELOPMENT -- VACCINE PROGRAM CONSIDERATIONS -- Target Population -- Vaccine Schedule, Efficacy, and Costs -- RESULTS -- READING LIST -- APPENDIX 8 Hepatitis C -- DISEASE BURDEN -- Epidemiology -- Disease Scenarios -- COST INCURRED BY DISEASE -- VACCINE DEVELOPMENT -- VACCINE PROGRAM CONSIDERATIONS -- Target Population -- Vaccine Schedule, Efficacy, and Costs -- RESULTS -- READING LIST -- APPENDIX 9 Herpes Simplex Virus -- DISEASE BURDEN -- Epidemiology -- Disease Scenarios -- Oral Infections -- Ocular Infections -- Central Nervous System Infections -- Genital Infections -- Neonatal Infections -- COST INCURRED BY DISEASE -- Oral and Ocular Infections -- Central Nervous System Infections -- Genital Infections -- Neonatal Infections -- VACCINE DEVELOPMENT -- VACCINE PROGRAM CONSIDERATIONS -- Target Population -- Vaccine Schedule, Efficacy, and Costs -- RESULTS -- READING LIST -- APPENDIX 10 Histoplasma capsulatum -- DISEASE BURDEN -- Epidemiology -- Disease Scenarios -- COST INCURRED BY DISEASE -- VACCINE DEVELOPMENT -- VACCINE PROGRAM CONSIDERATIONS -- Target Population -- Vaccine Schedule, Efficacy, and Costs -- RESULTS -- READING LIST -- APPENDIX 11 Human Papillomavirus -- DISEASE BURDEN -- Epidemiology -- Disease Scenarios -- COST INCURRED BY DISEASE -- VACCINE DEVELOPMENT…”

Tabla de Contenidos: “…Sicari and Stephen F. Badylak -- Hepatic localization of macrophage phenotypes during fibro genesis and resolution of fibrosis in mice and humans / Leonie Beljaars, Marlies Schippers, Catharina Reker-Smit, Fernando O. …”

Tabla de Contenidos: “…Microbial fact sheets -- 11.1 Bacterial pathogens -- Acinetobacter -- Aeromonas -- Burkholderia pseudomallei -- Campylobacter -- Enterobacter sakazakii -- Escherichia coli pathogenic strains -- Helicobacter pylori -- Klebsiella -- Legionella -- Leptospira -- Mycobacterium -- Pseudomonas aeruginosa -- Salmonella -- Shigella -- Staphylococcus aureus -- Tsukamurella -- Vibrio -- Yersinia -- 11.2 Viral pathogens -- Adenoviruses -- Astroviruses -- Caliciviruses -- Enteroviruses -- Hepatitis A virus -- Hepatitis E virus -- Rotaviruses and orthoreoviruses -- 11.3 Protozoan pathogens -- Acanthamoeba -- Balantidium coli -- Blastocystis…”

Tabla de Contenidos: “…Conradie Nutrient Patterns Associated with Fasting Glucose and Glycated Haemoglobin Levels in a Black South African Population doi: 10.3390/nu9010009 -- Jia Zheng, Xinhua Xiao, Qian Zhang, Tong Wang, Miao Yu and Jianping Xu Maternal Low-Protein Diet Modulates Glucose Metabolism and Hepatic MicroRNAs Expression in the Early Life of Offspring † doi: 10.3390/nu9030205 -- Alexander M. …”

Tabla de Contenidos: “…Gronning-Wang / LXR Regulates Hepatic ChREBPa Activity and Lipogenesis upon Glucose, but Not Fructose Feeding in Mice / Reprinted from: Nutrients 2017, 9, 678, doi: 10.3390/nu9070678. -- Wesley C. …”